Pyridine

Pyridine

SCHEMBL7770372

CC(=O)c1cccc(C#N)n1.I.c1ccncc1

nearest known ligand 0.55

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHECHRM1CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNG

The experimentally established mechanism targets of Pyridine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.42
AHR P35869 1/20 0.42
KDM4E B2RXH2 2/20 0.35
ALOX15 P16050 1/20 0.35
TSHR P16473 1/20 0.35
ACMSD Q8TDX5 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
TGFBR1 P36897 1/20 0.35
SOS2 Q07890 1/20 0.34
CES1 P23141 1/20 0.34
LMNA P02545 2/20 0.33
GRM4 Q14833 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP2D6 P10635 1/20 0.33
HIF1A Q16665 1/20 0.33
ADORA1 P30542 2/20 0.33
ADORA2A P29274 1/20 0.33
NAPRT Q6XQN6 1/20 0.33
P4HTM Q9NXG6 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7770340 0.89 AHR (0.49) ALDH1A1AHRKDM4EALOX15TSHR
Pyridine SCHEMBL8597415 0.79 AHR (0.40) ALDH1A1AHRKDM4EALOX15TSHR
SCHEMBL1244495 0.77 KDM4E (0.61) AHRKDM4EALOX15TSHRACMSD
SCHEMBL31098054 0.72 ALDH1A1 (0.42) ALDH1A1AHRKDM4EALOX15TSHR
SCHEMBL17963045 0.72 ALDH1A1 (0.42) ALDH1A1AHRKDM4EALOX15TSHR
SCHEMBL5387510 0.72 AHR (0.49) ALDH1A1AHRKDM4EALOX15TSHR
SCHEMBL2956687 0.72 AHR (0.49) AHRKDM4EALOX15TSHRACMSD
SCHEMBL15336497 0.72 AHR (0.42) AHRSOS2ADORA1ADORA2A
SCHEMBL9323548 0.71 AHR (0.46) AHRKDM4EALOX15TSHRACMSD
SCHEMBL9326696 0.71 AHR (0.46) ALDH1A1AHRKDM4EALOX15TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6248870-B1 OLIGO-2,6-PYRIMIDINE COMPLEXING AGENT. NYCOMED IMAGING AS (NO) 2001-06-19 US disclosed
US-5817774-A Unsymmetrical complexing agents and targeting immunoreagents useful in therapeutic and diagnostic compositions and methods STERLING WINTHROP INCORPORATION (US) 1998-10-06 US disclosed
US-5559214-A Unsymmetrical complexing agents and targeting immunoreagents useful in thearpeutic and diagnostic compositions and methods STERLING WINTHROP INC. (US) 1996-09-24 US disclosed
US-5539117-A 2-acetyl-6-cyanopyridines and their use as intermediates in the synthesis of oligo-2,6-pyridines GE HEALTHCARE AS (NO) 1996-07-23 US disclosed
US-5350696-A 2-acetyl-6-cyanopyridines and their use as intermediates in the synthesis of oligo-2,6-pyridines STERLING WINTHROP, INC. (US) 1994-09-27 US disclosed